Show simple item record

dc.contributor.authorMadhavan, D
dc.contributor.authorAustin, Andrew
dc.contributor.authorMorris, C
dc.date.accessioned2019-05-14T11:07:43Z
dc.date.available2019-05-14T11:07:43Z
dc.date.issued2019-05
dc.identifier.urihttps://orda.derbyhospitals.nhs.uk/handle/123456789/1916
dc.description.abstractWe describe the use of Cytosorb™, a synthetic extracorporeal haemoperfusion adsorption column, in the management of two patients with drug induced cholestasis and a third with alcoholic hepatitis and subsequent acute on chronic liver failure. Cytosorb was used in these patients to remove bilirubin and bile acids by supporting impaired excretory hepatic function, alleviating symptoms with the intention of serving as a bridge to endogenous recovery. The first two cases demonstrate favourable biochemical and symptomatic responses; the third case demonstrated a good biochemical response but subsequently died from the complications of multiple organ failure. These cases suggest Cytosorb™ be evaluated as an adjunct to support liver excretory functions in other arenas, such as acute liver failure or overdose. It remains unclear whether extracorporeal therapies removing liver toxins allow faster or more complete spontaneous recovery of endogenous function.en
dc.language.isoenen
dc.subjectCholestasisen
dc.subjectCytosorben
dc.subjectExtra-Corporealen
dc.subjectHaemabsorptionen
dc.subjectHaemoperfusionen
dc.subjectLiver Failureen
dc.subjectPruritisen
dc.titleNovel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment.en
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record